Valink Therapeutics

Drug Discovery · London, United Kingdom · Founded 2020 · Privately Held (backing)

Developer of a modular protein platform designed to facilitate the scalable discovery of bi-specific biologics. Valink Therapeutics is based in London, United Kingdom and was founded in 2020. It was valued at $12.6 million at its seed round in Nov 2023, the last priced event on record. It has raised $20.5 million across 1 recorded round; the latest was a $7.6 million seed round in Nov 2023.

PMV mark · valuation
$12.6M
Oct 2026
Priced at
its seed round
Nov 2023
Total raised
$20.5M
Last round
Seed Round
Nov 2023
What is Valink Therapeutics worth?
$12.6MPrivateMarketView mark · Oct 2026

Valued at $12.6M at its seed round, Nov 2023. Nothing has traded since.

Free account
More of Valink Therapeutics with a free account
  • ·The complete investor list: 18 names
  • ·Watch Valink Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Valink Therapeutics funding history

1 rounds
DateRoundRaisedPost-money
Nov 2023Seed Round$7.6M▮
Unlock post-money valuations

Membership and data by Private Market View

Valink Therapeutics valuation

Valink Therapeutics was valued at $12.6 million at its seed round in Nov 2023. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Valink Therapeutics raised?

Valink Therapeutics has raised $20.5 million in total; 1 of its rounds is on record. The largest on record was a $7.6 million seed round in Nov 2023.

Comparable companies

Comparable drug discovery names by valuation on PrivateMarketView: Ancilia Bio ($28 million), PAhR Therapeutics ($25 million) and Coding Bio ($6.6 million).

How Valink Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Valink Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Valink Therapeutics

What is Valink Therapeutics worth?
Valink Therapeutics is valued at $12.6M as of Oct 2026. Valued at $12.6M at its seed round, Nov 2023. Nothing has traded since.
How much has Valink Therapeutics raised?
Valink Therapeutics has raised $20.5M in total funding across 1 recorded rounds.
When did Valink Therapeutics last raise?
Valink Therapeutics last raised in Nov 2023 (Seed Round), raising $7.6M.